In vivo mouse model for analysis of hydroxysteroid (17beta) dehydrogenase 1 inhibitors.

Hydroxysteroid (17beta) dehydrogenase 1 (HSD17B1) catalyzes the reaction between the low active 17-ketosteroids and the highly active 17beta-hydroxysteroids. In the present study, we have generated transgenic (TG) mice expressing human (h) HSD17B1 under mouse mammary tumor virus (MMTV) promoter (MMTV-hHSD17B1TG mice). The MMTV-hHSD17B1TG mice were used to characterize HSD17B1 enzyme activity and properties of HSD17B1 inhibitor in vivo.

The efficacy of bovine lactoferrin in the treatment of cows with experimentally induced Escherichia coli mastitis.

The effect of bovine lactoferrin (Lf) was studied in experimental Escherichia coli mastitis, using enrofloxacin as a comparator. Mastitis was induced in six clinically healthy primiparous dairy cows by infusing 1500 colony-forming units of E. coli into a single udder quarter.

Disposition kinetics of lactoferrin in milk after intramammary administration.

Disposition kinetics of lactoferrin (Lf) purified from cheese whey was studied in the milk of Finnish Ayrshire cows after intramammary administration of 1 g of Lf into one udder quarter. Intramammary administration of 1 g of Lf increased Lf concentration in milk for several hours. Mean elimination half-life of Lf was 2.

Fumonisin B1-induced DNA damage in rat liver and spleen: effects of pretreatment with coenzyme Q10, L-carnitine, alpha-tocopherol and selenium.

Active oxygen radical species are reported to cause organ damage. This study was designed to determine whether oxidative stress contributed to the initiation or progression of hepatic and splenic cell DNA damage induced by fumonisin B1 (FB1) in rats. Another aim was to investigate the protective effects of the antioxidants coenzyme Q10 (CoQ10), L-carnitine, vitamin E (alpha-tocopherol) and selenium against DNA damage in the liver and spleen of rats treated with FB1.

The effect of sour milk as a postmilking teat dip for mastitis prevention in a dairy herd.

In a preliminary in vitro study, the growth of Staphylococcus aureus was totally inhibited during incubation for 24 h at 35 degrees C-37 degrees C in a solution of cooked commercial milk with 1% of uncooked commercial sour milk ("A piimä"). In a subsequent clinical trial, "A piimä" sour milk with 5% glycerol was used as a postmilking teat dip from February to June. Quarterly milk samples were drawn once a month aseptically from 133 cows.

Epidemiology of metabolic disorders in dairy cattle: association among host characteristics, disease, and production.

Logistic regression was used to investigate the effects of host characteristics, production, and 23 veterinary diagnoses on the odds of contracting seven metabolic disorders among 61,124 Finnish Ayrshire cows that calved during 1983. Cows in higher producing herds were at increased risk of parturient paresis, udder edema, and ketosis. Cows that had higher previous yields were at increased risk of parturient and nonparturient paresis and ketosis.

An epidemiological and genetic study on registered diseases in Finnish Ayrshire cattle. III. Metabolic diseases.

The epidemiology of clinical ketosis, hypocalcaemia and hypomagnesaemia was examined. In addition, the genetic variability of ketosis and parturient paresis was investigated. The data set consisted of the lactation records of 70,775 Finnish Ayrshire dairy cows.